Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
Egypt flag Egypt · Delayed Price · Currency is EGP
4.830
-0.170 (-3.40%)
At close: Aug 4, 2026

EGX:SIPC Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
46.5254.8822.7813.3118.245.42
Revenue Growth
41.43%140.93%71.17%-26.88%-59.93%-34.89%
Gross Profit
17.322.032.849.87.3118.75
Operating Income
6.9612.34-8.743.341.588.85
Net Income
2.1310.08-18.491.040.015.49
Earnings Per Share
0.010.04-0.070.000.000.02
EPS Growth
---7075.86%-99.74%-

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.521.940.610.420.154.87
Total Debt
23.7124.4632.3927.1920.6424.28
Net Cash (Debt)
-19.19-22.51-31.78-26.76-20.49-19.42
Net Cash Growth
------
Net Cash Per Share
-0.08-0.09-0.13-0.11-0.08-0.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
11.0810.78-0.293.414.7219.61
Capital Expenditures
-0.09-0.02-1.79-1.32-22-16.18
Free Cash Flow
1110.76-2.082.09-17.293.44
Free Cash Flow Growth
1558.62%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
37.18%40.14%12.47%73.63%40.17%41.28%
Operating Margin
14.97%22.49%-38.38%25.13%8.70%19.48%
Pretax Margin
7.37%21.05%-83.64%16.35%5.28%19.40%
Profit Margin
4.57%18.37%-81.15%7.82%0.08%12.09%
FCF Margin
23.64%19.60%-9.14%15.72%-94.97%7.57%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
567.5492.22-191.7319146.9148.70
P/FCF Ratio
109.8186.46-95.38-77.80
PS Ratio
25.9616.9514.4914.9915.445.89